Psychemedics Stock Analysis

PMD -  USA Stock  

USD 7.91  0.02  0.25%

The latest bullish price patterns experienced by current Psychemedics shareholders may encourage shareholders to take a closer look at the company as it is trading at a share price of 7.91 on 2,016 in trading volume. The company directors and management have been very successful in rebalancing the company assets at opportune times to take advantage of market volatility in May. The stock standard deviation of daily returns for 90 days investing horizon is currently 2.58. The current volatility is consistent with the ongoing market swings in May 2021 as well as with Psychemedics unsystematic, company-specific events.
Please check Your Equity Center.

Search Stock Analysis 

 
Refresh
The Psychemedics stock analysis report makes it easy to digest most publicly released information about Psychemedics and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Psychemedics stock analysis module also helps to analyze the Psychemedics price relationship with some important fundamental indicators such as market cap and management efficiency.

Psychemedics Stock Analysis Notes

About 18.0% of the company outstanding shares are owned by corporate insiders. The book value of Psychemedics was at this time reported as 2.26. The company recorded a loss per share of 0.7. Psychemedics next dividend is scheduled to be issued on the 20th of February 2020. The entity had 1:4 split on the 1st of August 2002. Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. Psychemedics Corporation was founded in 1986 and is headquartered in Acton, Massachusetts. Psychemedics operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 138 people. To find out more about Psychemedics contact Raymond Kubacki at 978 206 8220 or learn more at http://www.psychemedics.com.

Psychemedics Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Psychemedics' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Psychemedics or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
The company reported the last year's revenue of 21.36 M. Reported Net Loss for the year was (3.86 M) with profit before taxes, overhead, and interest of 4.89 M.
Psychemedics has about 2.83 M in cash with (4.08 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.51.
Roughly 18.0% of the company outstanding shares are owned by corporate insiders
Latest headline from www.equities.com: Psychemedics Corp. gains 1.6060 percent for June 10 - Equities.com

Psychemedics Market Capitalization

The company currently falls under 'Micro-Cap' category with total capitalization of 42.3 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Psychemedics's market, we take the total number of its shares issued and multiply it by Psychemedics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Psychemedics Profitablity

Psychemedics' profitability indicators refer to fundamental financial ratios that showcase Psychemedics' ability to generate income relative to its revenue or operating costs. If, let's say, Psychemedics is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Psychemedics' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Psychemedics' profitability requires more research than a typical breakdown of Psychemedics' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Net Profit Margin of (18.07) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (28.4) %, which entails that for every $100 of revenue, it lost -0.28.

Management Efficiency

The entity has Return on Asset of (14.71) % which means that on every $100 spent on asset, it lost $14.71. This is way below average. In the same way, it shows return on shareholders equity (ROE) of (26.31) %, meaning that it generated no profit with money invested by stockholders. Psychemedics management efficiency ratios could be used to measure how well psychemedics manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 17th of June 2021, Psychemedics holds the Risk Adjusted Performance of 0.0461, coefficient of variation of 1622.35, and Semi Deviation of 2.04. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Psychemedics, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We have collected data for nineteen technical drivers for Psychemedics, which can be compared to its competitors. Please check Psychemedics information ratio, and the relationship between the downside deviation and value at risk to decide if Psychemedics is priced some-what accurately, providing market reflects its current price of 7.91 per share. Given that Psychemedics has jensen alpha of 0.1549, we recommend you to check out Psychemedics's recent market performance to make sure the company can sustain itself at a future point.

Psychemedics Price Movement Analysis

The output start index for this execution was fourty-nine with a total number of output elements of twelve. The Exponential Moving Average is calculated by weighting recent values of Psychemedics more heavily than older values. View also all equity analysis or get more info about exponential moving average overlap studies indicator.

Psychemedics Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Psychemedics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Psychemedics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Psychemedics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Psychemedics Predictive Daily Indicators

Psychemedics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Psychemedics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Psychemedics Forecast Models

Psychemedics time-series forecasting models is one of many Psychemedics' stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Psychemedics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Psychemedics Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Psychemedics stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Psychemedics shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Psychemedics. By using and applying Psychemedics Stock analysis, traders can create a robust methodology for identifying Psychemedics entry and exit points for their positions.
Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. Psychemedics Corporation was founded in 1986 and is headquartered in Acton, Massachusetts. Psychemedics operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 138 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Psychemedics to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Equity Forecasting Now

   

Equity Forecasting

Use basic forecasting models to generate price predictions and determine price momentum
All  Next Launch Module
Please check Your Equity Center. Note that the Psychemedics information on this page should be used as a complementary analysis to other Psychemedics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Complementary Tools for Psychemedics Stock analysis

When running Psychemedics stock analysis, check to measure Psychemedics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Psychemedics is operating at the current time. Most of Psychemedics' stock examination focuses on studying past and present price action to predict the probability of Psychemedics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Psychemedics' price. Additionally, you may evaluate how the addition of Psychemedics to your portfolios can decrease your overall portfolio volatility.
Equity Search
Search for activelly-traded equities including funds and ETFs from over 30 global markets
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
The market value of Psychemedics is measured differently than its book value, which is the value of Psychemedics that is recorded on the company's balance sheet. Investors also form their own opinion of Psychemedics stock's value that differs from its market value or its book value, called intrinsic value, which is Psychemedics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Psychemedics' market value can be influenced by many factors that don't directly affect Psychemedics underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Psychemedics' stock value and its price as these two are different measures arrived at by different means. Investors typically determine Psychemedics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Psychemedics' stock price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.